Transdermal Patch Market
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.
The global Transdermal Patch market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage Market Size & Forecast, Major Company of Product Type etc. :
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
Get More Information about this Report and TOC @ https://www.planetmarketreports.com/reports/global-transdermal-patch-market-6658
Demand Coverage Market Size & Forecast, Consumer Distribution :
The fentanyl transdermal system patch is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
Nicotine skin patches are used to help people stop smoking cigarettes. They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.
Buprenorphine patches are used to relieve severe pain in people who are expected to need pain medication around the clock for a long time and who cannot be treated with other medications. It is in a class of medications called opiate narcotic analgesics. It works by changing the way the brain and nervous system respond to pain.
Transdermal clonidine is used alone or in combination with other medications to treat high blood pressure. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. It works by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body.
Oxybutynin transdermal patches are used to treat an overactive bladder a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination . Oxybutynin is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles.
Others
Company Coverage Sales data, Main Products & Services etc. :
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Major Region Market
North America
Europe
Asia-Pacific
South America